Eastern tradition · Practitioner Supply

Berberine 小檗碱 · 黄连素

An alkaloid from Chinese herbs (Coptis / Huang Lian) with human RCTs on metabolic health and an AMPK/sirtuin longevity rationale.

126ClinicalTrials.gov matched
125PubMed RCT records
107Meta-analysis records
11+PubMed records
BerberineKey active compound

Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.

Origin & tradition

Berberine is the active alkaloid in Huang Lian (黄连) and related herbs, long used in Chinese medicine for digestive and heat-clearing applications.

Why longevity buyers care

Key active: Berberine (isoquinoline alkaloid).

Berberine activates AMPK — the same energy-sensing pathway as metformin — and is studied for SIRT1 activation and autophagy, with human RCTs on glucose, lipids and metabolic syndrome.

Effect summary

Studied health outcomes

Editorial summary — This table is curated by hand from published research consensus, not automatically calculated from our trial database. Grades reflect our interpretation of the literature. Treat as a starting point, not a definitive verdict. See the Evidence panel below for the underlying trial and paper counts sourced directly from ClinicalTrials.gov and PubMed.
Health outcomeEffectMagnitudeGrade
Fasting blood glucoseDecreasesStrongA
HbA1cDecreasesStrongA
LDL cholesterolDecreasesModerateA
TriglyceridesDecreasesModerateA
Body weightDecreasesMinorB
AMPK activationIncreasesStrongB
Gut microbiome diversityIncreasesModerateB

Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data

Dosage guidance

How Berberine is typically used

Typical dose
500 mg, 2–3× daily (1,000–1,500 mg total)
Form
capsule (berberine HCl)
Timing
with or before meals to reduce GI upset

Dihydroberberine (DHB) achieves comparable effects at ~100–200 mg with far better bioavailability. Do not combine with CYP3A4-metabolized drugs without medical supervision.

Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.

Evidence summary

What the research actually says

85Evidence confidence
Extensive human-trial evidence125 randomized controlled trials · 107 meta-analyses / systematic reviews

Human RCTs (metabolic syndrome, NAFLD); mechanistic longevity rationale

Berberine activates AMPK — the same energy-sensing pathway as metformin — and is studied for SIRT1 activation and autophagy, with human RCTs on glucose, lipids and metabolic syndrome.

126registered clinical trials reference this intervention
3selected from 11+ PubMed papers (longevity / aging angle)
Key active: Berberine chloride (C20H18ClNO4) · ChEMBL CHEMBL12089 · max clinical phase 1 · natural product

According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed, compound data from EMBL-EBI ChEMBL. Counts auto-refresh weekly; last checked 2026-07-19. They include trials across many endpoints, not only longevity.

Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.

Compare the evidence

Related ingredients

Suppliers

4 suppliers in our directory carry Berberine

Request sourcing help